Ceramide lipids, a known lipotoxic molecule among sphingolipids, can interfere with insulin signaling pathways and exacerbate hepatic and systemic insulin resistance, which is one of the primary drivers of non-alcoholic fatty liver disease (NAFLD) [49]. The gene discussed is INS; the disease is Insulin resistance.